-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Acute and chronic liver failure (ACLF) is defined as the acute deterioration of liver function in individuals with pre-existing chronic liver disease, resulting in multisystem organ failure and high short-term mortality
Acute and chronic liver failure (ACLF) is defined as the acute deterioration of liver function in individuals with pre-existing chronic liver disease, resulting in multisystem organ failure and high short-term mortality
This study collected 124 ACLF patients with liver disease and healthy individuals, cirrhosis, and ALF patients between January 2015 and September 2018
The results of the study showed that plasma SOD levels in ACLF patients were statistically higher than in controls (healthy controls and patients with cirrhosis); however, the levels were not different from those in ALF patients
statistics
Figure: Differences in expression of superoxide dismutase levels
This study confirmed that ACLF patients can be divided into high-risk group and low-risk group according to the plasma SOD level on admission
This study confirmed that ACLF patients can be divided into high-risk group and low-risk group according to the plasma SOD level on admission
Zhen Tian.
Association between plasma level of superoxide dismutase and survival of patients with acute-on-chronic liver failureLeave
a message here
